Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 42
Filtrar
1.
Vox Sang ; 119(3): 257-264, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38223953

RESUMO

BACKGROUND AND OBJECTIVES: Serological HTLV-1/2 screening is mandatory for blood donor candidates in Brazil. Our objective was to analyse HTLV test results in blood donors submitted for screening and confirmatory assays in a Brazilian blood bank. MATERIALS AND METHODS: Retrospective analysis (2017-2022) results of chemiluminescence immunoassays and confirmatory tests for HTLV-1/2 in reactive donors were performed. During the analysed period, three sets of assays were used: (1) Architect rHTLV-I/II + HTLV Blot 2.4 (Western blot [WB]); (2) Alinity s HTLV I/II Reagent Kit + INNO-line immunoassay (LIA) HTLV I/II Score (LIA); (3) Alinity + WB. RESULTS: The analysed period comprised a total of 1,557,333 donations. The mean percentage of HTLV reactive donors using the Architect assay was 0.14%. With the change to the Alinity assay, that percentage dropped 2.3-fold (0.06%). The reactivity rate in the confirmatory tests (1064 samples) ranged from 13.5% to 30.2%, whereas 58.3%-85.9% of samples were non-reactive. The highest rates of positive (30.2%) and indeterminate (11.5%) results were seen using LIA. Considering all analysed samples, those with signal/cut-off ratio (S/CO) >50 were positive in confirmatory tests (positive predictive value, PPV = 100%), whereas samples with S/CO ≤6 are very unlikely to be truly positive (PPV = 0). CONCLUSION: The use of the Alinity assay reduced the frequency of false-positive results. Confirmatory tests are important to identify true HTLV infection in blood donors, because more than 58% of initially reactive individuals are confirmed as seronegative. Categorizing S/CO values is useful for assessing the likelihood of true HTLV-1/2 infection.


Assuntos
Infecções por HTLV-I , Vírus Linfotrópico T Tipo 1 Humano , Humanos , Doadores de Sangue , Estudos Retrospectivos , Vírus Linfotrópico T Tipo 2 Humano , Western Blotting , Linfócitos T
2.
Bol. venez. infectol ; 34(1): 15-25, ene-jun 2023.
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1512774

RESUMO

Introducción: La infección transmitida por transfusión (ITT) es producto de la inoculación directa de un agente infeccioso específico desde la unidad de sangre al huésped susceptible. Los marcadores serológicos positivos responden a características epidemiológicas no detectadas en miembros de la población aparentemente saludable. Objetivo general: Determinar la prevalencia de marcadores infecciosos y las características sociodemográficas en unidades sanguíneas procesadas de donantes que asisten al banco de sangre del Complejo Hospitalario Universitario "Ruíz y Páez" de Ciudad Bolívar - Estado Bolívar, período junio 2019 - junio 2022. Metodología: Se trató de un estudio de tipo descriptivo, retrospectivo, no experimental. El universo estuvo conformado por 13 016 unidades sanguíneas, 414 muestras fueron reactivas, que reportaron un total de 434 serologías positivas. Resultados: Se apreció una prevalencia global de 3,34 % para cualquier ITT; el marcador infeccioso más frecuente fue sífilis con el 60,83 % y una prevalencia de 2,03 %. Tomando en cuenta las características sociodemográficas predominantes: género masculino, 65,94 %; grupo etario 38-47 años, 28,74 %; ocupación obrera, 24,88 %; provenientes de Ciudad Bolívar, 84,06 %. Las muestras con coinfección representaron un 4,58 %, siendo la combinación VIH+Sífilis la más frecuente 1,45 %. El año 2021 destacó con 35,25 % serologías positivas. Conclusiones: La prevalencia de marcadores infecciosos se considera no despreciable. Se debe reforzar la prevención y cura de las enfermedades infecciosas trasmisibles en miembros de la población aparentemente saludable, así como también redirigir las estrategias en el manejo de seguridad transfusional.


Introduction: Transfusion-transmitted infection (ITT) is the direct inoculation of a specific infectious agent from the blood unit to the susceptible host. Positive serological markers respond to epidemiological characteristics not detected in members of the apparently healthy population. General objective: Determine the prevalence of infection markers and sociodemographic characteristics in processed blood units of donors attending the blood bank of the "Ruíz y Páez" University Hospital Complex in Ciudad Bolívar - Bolivar State, period June 2019 - June 2022. Methodology: This was a descriptive, retrospective, nonexperimental study. The universe consisted of 13 016 blood units, 414 samples were reactive, which reported a total of 434 positive serologies. Results: An overall prevalence of 3.34 % was found for any ITT; the most frequent infection markers were syphilis with 60.83% and a prevalence of 2.03 %. Taking into account the predominant sociodemographic characteristics: male gender, 65.94 %; age group 38-47 years, 28.74 %; labor occupation, 24.88 %; from Ciudad Bolivar, 84.06 %. The samples with coinfection represented 4.58 %, being the combination HIV+Syphilis the most frequent 1.45 %. Year 2021 stood out with 35.25 % positive serologies. Conclusions: The prevalence of infection markers is considered not negligible. The prevention and cure of communicable infectious diseases in members of the apparently healthy population should be strengthened, as well as redirecting strategies in transfusion safety management.

3.
Rev. Soc. Bras. Med. Trop ; 56: e0206, 2023. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1521620

RESUMO

ABSTRACT Background: Chagas disease (ChD) is a neglected tropical disease that is caused by the protozoan parasite Trypanosoma cruzi and can negatively impact quality of life (QoL). This study aimed to assess and compare QoL between individuals with and without ChD. Methods: This cross-sectional study was performed within a concurrent cohort study (REDS). The participants were derived from two blood donation centers: São Paulo capital and Montes Claros, Minas Gerais, Brazil. Participants with ChD were identified in blood donations by serological diagnosis between 2008 and 2010, and those without ChD were donors with negative serology identified during the same period. QoL was assessed using the World Health Organization Quality of Life-BREF questionnaire. Logistic regression was used to compare sociodemographic and clinical characteristics between the groups, and mean, standard deviation, and beta regression were used to compare QoL. Results: In total, 611 individuals participated in the study (328 with ChD and 283 without ChD). Participants with ChD had lower QoL in the physical (p=0.02) and psychological (p<0.01) domains than did individuals without CD. Conclusions: Individuals with ChD had worse QoL perceptions. These results provide a comprehensive understanding of the impact of ChD on individuals' QoL, while also highlighting potential opportunities for improving the care and treatment of those affected.

4.
Braz J Microbiol ; 53(4): 1995-2001, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36100808

RESUMO

Oral transmission is the main route of hepatitis E virus (HEV) infection; however, genotypes 3 and 4 may also be transmitted by blood transfusion. Individuals who need blood products are often immunosuppressed, which increase the risk of severe disease and death by HEV. Despite this, blood banks in Brazil do not screen for HEV and epidemiological studies in this population are rare; this is an important issue as HEV-3 is frequently identified in the country. Herein, we analyzed the seroprevalence and risk factors for HEV seropositivity in donor candidates/blood donors from Northeast Brazil. Nine hundred and ninety-six donor candidates/blood donors from Foundation of Hematology and Hemotherapy of Pernambuco (HEMOPE) were interviewed regarding socioeconomic, sociodemographic, and behavioral data and analyzed for anti-HEV IgG. Anti-HEV IgG was detected using the HEV IgG (EUROIMMUN) kit. Associations between seropositivity and potential risk factors were analyzed by the χ2 test and Fisher's exact test. Seroprevalence was 0.9% (9/996), 77.77% (7/9) and 22.22% (2/9) in blood donors and donor candidates, respectively. HEV seropositivity was associated with male (OR: 11.65; CI: 0.6755-200.9; p = 0.0163), income higher than BRL 20,000/month (p = 0.0002), and lake bathing (OR: 4.553; CI: 1.391-15.25; p = 0.0258). Importantly, about 43% (3/7) of anti-HEV positive donors made their first donation more than 20 years ago, which must be taken as a warning sign, given the possibility that these individuals may have been infected after registration as donors. Finally, the report of HEV seropositivity, especially in regular blood donors, as well as the identification of potential risk factors, reinforces the need for viral screening in Brazilian blood banks.


Assuntos
Vírus da Hepatite E , Hepatite E , Masculino , Humanos , Vírus da Hepatite E/genética , Estudos Soroepidemiológicos , Doadores de Sangue , Hepatite E/epidemiologia , Brasil/epidemiologia , Anticorpos Anti-Hepatite , Imunoglobulina G , Fatores de Risco , RNA Viral
5.
Emerg Infect Dis ; 28(4): 734-742, 2022 04.
Artigo em Inglês | MEDLINE | ID: mdl-35180375

RESUMO

During epidemics, data from different sources can provide information on varying aspects of the epidemic process. Serology-based epidemiologic surveys could be used to compose a consistent epidemic scenario. We assessed the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG in serum samples collected from 7,837 blood donors in 7 cities of Brazil during March-December 2020. Based on our results, we propose a modification in a compartmental model that uses reported number of SARS-CoV-2 cases and serology results from blood donors as inputs and delivers estimates of hidden variables, such as daily values of SARS-CoV-2 transmission rates and cumulative incidence rate of reported and unreported SARS-CoV-2 cases. We concluded that the information about cumulative incidence of a disease in a city's population can be obtained by testing serum samples collected from blood donors. Our proposed method also can be extended to surveillance of other infectious diseases.


Assuntos
COVID-19 , Epidemias , Anticorpos Antivirais , Doadores de Sangue , Brasil/epidemiologia , COVID-19/epidemiologia , Humanos , Imunoglobulina G , SARS-CoV-2 , Estudos Soroepidemiológicos
6.
Front Public Health ; 10: 1056332, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36620228

RESUMO

Introduction: Sociodemographic and behavioral factors are usually associated with the unsuitability to donate blood. Understanding the reasons behind the exclusion of blood bags is crucial for reducing donor deferral rates. This study aimed to characterize the profile of unsuitable donors in the Blood Center of the northern Brazilian state of Amazonas. Methods: This is a retrospective study, based on documentary analysis of electronic medical records obtained in the Hematology and Hemotherapy Foundation of the state of Amazonas. This study included all individuals with complete medical records (n = 87,463) who tried to donate blood between 2017 and 2019. Results: The overall rate of donor unsuitability was 19.12% (n = 16,627) and the main reason was poor nutritional status (15.17%), followed by chronic health problems (11.40%), risky sexual behavior (9.5%) and exposure to risk (8.83%). High blood pressure figured as the leading cause of unsuitability among chronic health conditions (85.19%), while having sex with multiple partners (92.63%) was the main sexual risk behavior. The risk of exposure to malaria was responsible for 99.45% of unsuitability among those who were unsuitable due to exposure to risk factors. Deferral rates were associated with increasing age and replacement donation, which was the predominant type of donation. Women had the highest rates of unsuitability, mainly during the first donation (37.04%). Discussion: This study provides the first known profile of blood donor unsuitability in the Brazilian Amazon and raises awareness of the region-specific needs that must be met to reduce blood donor unsuitability.


Assuntos
Doação de Sangue , Doadores de Sangue , Humanos , Feminino , Estudos Retrospectivos , Brasil , Fatores de Risco
7.
Transfus Med ; 31(6): 421-430, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34693573

RESUMO

OBJECTIVE: This work aimed to establish the effects of the COVID-19 pandemic on blood collection and blood product usage at the end of the first year. BACKGROUND: The arrival of SARS-CoV-2 to Colombia on March 6, 2020, triggered closure of borders and mandatory lockdown from March 23, 2020. METHODS/MATERIALS: The Colombian National Institute of Health administers the National database of confirmed cases of SARS-CoV-2 and the National Haemovigilance System. We examined positive SARS-CoV-2 cases identified between March 6, 2020, and March 6, 2021, using positive RT-PCR testing (72.8%) or reactive antigen (27.2%). We also analysed accepted and deferred donors' information provided by 100% of blood banks and transfused patients notified by 83% of health care facilities nationwide, between March 1, 2019, to February 28, 2021. RESULTS: Colombia registered 2 273 245 SARS-CoV-2 cases. From these, 60 412 people died from COVID-19 (2.7%) and 2 172 418 individuals recovered (95.6%). There were 11 659 216 SARS-CoV-2 processed samples nationwide. People between the ages of 20 and 39 years concentrated 44.4% of the SARS-CoV-2 cases. There were 773 569 blood donations, mainly from a 20-39-year-old population (60.5%). The pandemic caused a reduction of 155 393 blood donations (16.7%) and 51 823 total deferrals (33.7%). An 18.4% drop in volunteer donors and a 37.3% increase in donations from family/replacements members were observed. There were 399 453 transfused patients and 1 179 895 blood components administered (-8.7% and - 13.9% compared to March 2019-February 2020). CONCLUSION: Mandatory lockdowns in Colombia decreased blood collection and usage, resulting in a reduction of blood components transfused to individual patients.


Assuntos
Bancos de Sangue , Segurança do Sangue , COVID-19 , Adulto , Bancos de Sangue/estatística & dados numéricos , Doadores de Sangue , Colômbia/epidemiologia , Controle de Doenças Transmissíveis , Humanos , Pandemias , Adulto Jovem
8.
Vox Sang ; 115(7): 548-554, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32364276

RESUMO

BACKGROUND: In Argentina, with the aim of moving to a safe supportive and inclusive National Blood System, in September 2015 the Ministry of Health stipulated that eligibility criteria for blood donation should only take into account the so-called 'risk practices', focusing on a 'gender-neutral' policy. The aim of this study is to demonstrate the impact of such regulation on the prevalence of STI in the population of blood donors in Argentina, through the analysis of the scientific evidence obtained from 174 074 donors from a large central region of the country, focused on a regional Blood Bank for a 6-year period (pre- and post-entry into force of the regulations). MATERIALS AND METHODS: To analyse the evolution of prevalence rates of STI, two periods of 3 years each were evaluated: The first period (P1) lasted from 16 September 2012 to 15 September 2015 (prior to the entry into force of the law) and the second one (P2) from 16 September 2015 to 15 September 2018 (after the entry into force of the law). RESULTS: A total of 82 838 subjects were enrolled in P1 and 91 236 in P2. The results show a significantly lower prevalence of HCV (P = 0·029), HBV (P = 0·028) and syphilis (P = 0·001) in P2, while no difference was observed for HIV infection (P = 0·60). CONCLUSION: This study evidenced that the implementation of a 'gender-neutral' policy based on individual risk-assessment deferral criteria maintained the safety of blood supply and decreased the prevalence of STI among blood donors.


Assuntos
Bancos de Sangue/organização & administração , Doadores de Sangue/estatística & dados numéricos , Infecções por HIV/epidemiologia , Política Organizacional , Sexismo , Sífilis/epidemiologia , Adulto , Argentina , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Medição de Risco
9.
Heliyon ; 6(5): e03869, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-32395652

RESUMO

A retrospective, cross-sectional study was conducted to determine the frequency of human parvovirus B19 (B19V) infected individuals, viral loads and immunity among blood donors from Argentina, in a post-epidemic outbreak period. B19V DNA and specific IgG were tested in minimum study samples of donors attending a blood bank at Córdoba, Argentina, in 2014. Anti-B19V IgM and viral loads were determined in B19V-positive plasma samples. Seven of 731 samples (0.96%) resulted positive, corresponding to individuals aged 32-53 years, four of them repeat donnors and three first-time donors. Viral loads were <103 IU/mL. None had IgM and 6/7 had IgG, one of them at a high level (in the range of 100-200 IU/ml, and the remaining 5 at low to medium level, 5-50 IU/ml). Thus one case was classified as acute infection (DNA+/IgM-/IgG-) and six as potentially persistent infections (DNA+/IgM-/IgG+). No coinfections with other pathogens of mandatory control in the pre-transfusion screening were detected. Prevalence of IgG was 77.9% (279/358). This study provides the first data of B19V prevalence in blood donors in Argentina, demonstrating high rates of acute and persistent B19V infections and high prevalence of anti-B19V IgG in a post-epidemic period. Further research is needed to elucidate mechanisms/factors for B19V persistence as well as follow-up of recipients in the context of haemo-surveillance programs, contributing to the knowledge of B19V and blood transfusion safety.

10.
Transfus Med ; 30(2): 148-156, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31820508

RESUMO

OBJECTIVES: The present study aimed to develop strategies for genotyping DO*HY (Dombrock system) and DI*A/DI*B (Diego system) alleles and to evaluate the impact of genomic and self-declared ancestry on rare donor screening in admixed populations. BACKGROUND: The antigens Hy and Dib demonstrate clinical importance. The lack of antisera for the serological evaluation of these antigens makes it necessary to develop molecular methods. In addition, considering that some rare red blood cell phenotypes present differences in frequency between ethnic groups, it is important to assess the applicability of self-declared ancestry in the search for rare donors in admixed populations. METHODS: DO*HY and DI*A/DI*B genotyping based on real-time polymerase chain reaction (PCR) was standardised. A total of 457 blood donors clustered by self-defined skin colour/race categories were genotyped. Furthermore, individual genomic ancestry was used in the analyses. RESULTS: The assays developed are reproducible and provide satisfactory results even at low concentrations of DNA, which make them useful in situations where the DNA is scarce, such as dried blood spots on filter paper, or when screening for pooled samples. No significant difference was observed in the frequencies of the DI*A, DI*B and DO*HY, comparing the self-declared White (branco) donors with those who are Black (preto) and Brown (pardo). CONCLUSION: Real-time PCR, especially using pooled samples, is a promising strategy to screen rare blood donors. Although both self-reported race/colour and some blood group phenotypes are associated with ancestry, the results point to a greater complexity in the application of self-declared race/colour in the screening of rare donors in admixed populations.


Assuntos
Doadores de Sangue , Antígenos de Grupos Sanguíneos/genética , Tipagem e Reações Cruzadas Sanguíneas , Seleção do Doador , Etnicidade/genética , Técnicas de Genotipagem , Autorrelato , Feminino , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA